238 related articles for article (PubMed ID: 30385303)
1. Sarcomere variants in arrhythmogenic cardiomyopathy: Pathogenic factor or bystander?
Chen K; Rao M; Guo G; Chen X; Chen L; Song J
Gene; 2019 Mar; 687():82-89. PubMed ID: 30385303
[TBL] [Abstract][Full Text] [Related]
2. Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC).
Murray B; Hoorntje ET; Te Riele ASJM; Tichnell C; van der Heijden JF; Tandri H; van den Berg MP; Jongbloed JDH; Wilde AAM; Hauer RNW; Calkins H; Judge DP; James CA; van Tintelen JP; Dooijes D
J Cardiovasc Electrophysiol; 2018 Jul; 29(7):1004-1009. PubMed ID: 29709087
[TBL] [Abstract][Full Text] [Related]
3. Variants in
Ferradini V; Parca L; Martino A; Lanzillo C; Silvetti E; Calò L; Caselli S; Novelli G; Helmer-Citterich M; Sangiuolo FC; Mango R
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34067482
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
5. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
6. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
Topriceanu CC; Pereira AC; Moon JC; Captur G; Ho CY
Circulation; 2024 Jan; 149(2):107-123. PubMed ID: 37929589
[TBL] [Abstract][Full Text] [Related]
8. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.
Wang J; Wang Y; Zou Y; Sun K; Wang Z; Ding H; Yuan J; Wei W; Hou Q; Wang H; Liu X; Zhang H; Ji Y; Zhou X; Sharma RK; Wang D; Ahmad F; Hui R; Song L
Eur J Heart Fail; 2014 Sep; 16(9):950-7. PubMed ID: 25132132
[TBL] [Abstract][Full Text] [Related]
9. Absence of a primary role for TTN missense variants in arrhythmogenic cardiomyopathy: From a clinical and pathological perspective.
Chen K; Song J; Wang Z; Rao M; Chen L; Hu S
Clin Cardiol; 2018 May; 41(5):615-622. PubMed ID: 29750433
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
[TBL] [Abstract][Full Text] [Related]
11. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing.
Lopes LR; Zekavati A; Syrris P; Hubank M; Giambartolomei C; Dalageorgou C; Jenkins S; McKenna W; ; Plagnol V; Elliott PM
J Med Genet; 2013 Apr; 50(4):228-39. PubMed ID: 23396983
[TBL] [Abstract][Full Text] [Related]
12. Deleterious Rare Desmosomal Variants Contribute to Hypertrophic Cardiomyopathy and Are Associated With Distinctive Clinical Features.
Wu G; Liu J; Ruan J; Yu S; Wang L; Zhao S; Wang S; Kang L; Wang J; Song L
Can J Cardiol; 2022 Jan; 38(1):41-48. PubMed ID: 34500006
[TBL] [Abstract][Full Text] [Related]
13. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
Ingles J; Burns C; Bagnall RD; Lam L; Yeates L; Sarina T; Puranik R; Briffa T; Atherton JJ; Driscoll T; Semsarian C
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408708
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
de Marvao A; McGurk KA; Zheng SL; Thanaj M; Bai W; Duan J; Biffi C; Mazzarotto F; Statton B; Dawes TJW; Savioli N; Halliday BP; Xu X; Buchan RJ; Baksi AJ; Quinlan M; Tokarczuk P; Tayal U; Francis C; Whiffin N; Theotokis PI; Zhang X; Jang M; Berry A; Pantazis A; Barton PJR; Rueckert D; Prasad SK; Walsh R; Ho CY; Cook SA; Ware JS; O'Regan DP
J Am Coll Cardiol; 2021 Sep; 78(11):1097-1110. PubMed ID: 34503678
[TBL] [Abstract][Full Text] [Related]
16. Genetics of hypertrophic cardiomyopathy: A review of current state.
Sabater-Molina M; Pérez-Sánchez I; Hernández Del Rincón JP; Gimeno JR
Clin Genet; 2018 Jan; 93(1):3-14. PubMed ID: 28369730
[TBL] [Abstract][Full Text] [Related]
17. Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.
Ghidoni A; Elliott PM; Syrris P; Calkins H; James CA; Judge DP; Murray B; Barc J; Probst V; Schott JJ; Song JP; Hauer RNW; Hoorntje ET; van Tintelen JP; Schulze-Bahr E; Hamilton RM; Mittal K; Semsarian C; Behr ER; Ackerman MJ; Basso C; Parati G; Gentilini D; Kotta MC; Mayosi BM; Schwartz PJ; Crotti L
Circ Genom Precis Med; 2021 Apr; 14(2):e003097. PubMed ID: 33566628
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy.
Kaski JP; Syrris P; Esteban MT; Jenkins S; Pantazis A; Deanfield JE; McKenna WJ; Elliott PM
Circ Cardiovasc Genet; 2009 Oct; 2(5):436-41. PubMed ID: 20031618
[TBL] [Abstract][Full Text] [Related]
19. Whole exome sequencing with genomic triangulation implicates CDH2-encoded N-cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy.
Turkowski KL; Tester DJ; Bos JM; Haugaa KH; Ackerman MJ
Congenit Heart Dis; 2017 Mar; 12(2):226-235. PubMed ID: 28326674
[TBL] [Abstract][Full Text] [Related]
20. Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review.
Koshy L; Ganapathi S; Jeemon P; Madhuma M; Vysakh Y; Lakshmikanth LR; Harikrishnan S
Indian J Med Res; 2023 Aug; 158(2):119-135. PubMed ID: 37787257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
